15/07/2026
Global HIV Response in Jeopardy as Funding Cuts Trigger 38% Plunge in PrEP Uptake
Just one year after sweeping funding reductions were enacted, the global fight against HIV is facing its most significant setback in a decade. New data released by UNAIDS reveals a stark and alarming reality: in 62 countries, the uptake of Pre-Exposure Prophylaxis (PrEP)—the highly effective daily pill that prevents HIV infection—has crashed by 38% between 2024 and 2025.
The figures, described by health officials as "devastating," are the first quantitative measure of the damage wrought by last year's budget cuts. While PrEP has long been hailed as a cornerstone of modern prevention strategy—empowering at-risk populations to stay negative—the sharp drop in access means that hundreds of thousands of people have been left vulnerable to infection during a critical window in the global eradication effort.
"The math is simple: when you defund prevention, you fund the pandemic," said one senior global health analyst familiar with the report. "We are not just seeing a dip in pills distributed; we are witnessing the reversal of hard-won behavioral and logistical gains. In many of these 62 nations, supply chains have broken, clinics have closed their prevention wings, and community health workers—the very backbone of the PrEP rollout—have been laid off."
The timing of this crisis is particularly tragic. Just prior to the cuts, many low- and middle-income countries were on the cusp of achieving the "95-95-95" targets set by UNAIDS (95% of people living with HIV knowing their status, 95% on treatment, and 95% virally suppressed). The 38% reduction in PrEP uptake is not merely a statistic; it is a projection of future infections. Epidemiologists warn that for every percentage point drop in prevention coverage, new infections will inevitably rise within 12 to 18 months, burdening healthcare systems already stretched thin.
This global slump is not a failure of science—PrEP remains over 99% effective when taken as prescribed—but a failure of political will. The funding gap has hit lower-income nations the hardest, where international aid constitutes the majority of the HIV budget. As donor governments pivot to domestic priorities, the most marginalized communities—s*x workers, men who have s*x with men, and young women in sub-Saharan Africa—are bearing the brunt of the shortfall.
We must protect the progress towards ending AIDS.
To allow this trajectory to continue would be to squander a generation of medical and social progress. The 38% decline is a warning shot. It tells us that the end of AIDS is not inevitable; it is conditional on sustained investment, political courage, and a recommitment to equitable healthcare.
As world leaders prepare for upcoming budget cycles, the data demands an immediate response: restore funding, rebuild supply chains, and rehire the community advocates who ensure PrEP reaches those who need it most. The science to end AIDS exists. What we lack, right now, is the collective resolve to pay for it. History will not judge us kindly if we let a fiscal decision undo a medical miracle.
Executive Director
Yobe State Agency for Control of AIDS
